We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1.86B
AUM Growth
+$115M
Cap. Flow
+$48.6M
Cap. Flow %
2.61%
Top 10 Hldgs %
53.28%
Holding
1,260
New
103
Increased
238
Reduced
231
Closed
77

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$8.78M
2
AMZN icon
Amazon
AMZN
+$5.64M
3
DIS icon
Walt Disney
DIS
+$5.57M
4
PLTR icon
Palantir
PLTR
+$4.68M
5
RING icon
iShares MSCI Global Gold Miners ETF
RING
+$4.35M

Sector Composition

Rank Sector Weight
1 Technology 26.35%
2 Financials 23.03%
3 Consumer Discretionary 16.24%
4 Communication Services 11.99%
5 Healthcare 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
776
Ingersoll Rand
IR
$30.5B
$19.1K ﹤0.01%
388
WAT icon
777
Waters Corp
WAT
$40.7B
$19K ﹤0.01%
67
ALKS icon
778
Alkermes
ALKS
$7.95B
$19K ﹤0.01%
1,019
+400
+65% +$8.19K
HRL icon
779
Hormel Foods
HRL
$11.9B
$18.9K ﹤0.01%
396
ALLE icon
780
Allegion
ALLE
$13.4B
$18.8K ﹤0.01%
150
TMUS icon
781
T-Mobile US
TMUS
$195B
$18.8K ﹤0.01%
150
-260
-63% -$32.8K
FITB
782
Fifth Third Bancorp
FITB
$49.5B
$18.7K ﹤0.01%
500
CDK
783
DELISTED
CDK Global, Inc.
CDK
$18.7K ﹤0.01%
345
SMMT icon
784
Summit Therapeutics
SMMT
$11B
$18.6K ﹤0.01%
3,170
+1,200
+61% +$7.74K
SQM icon
785
Sociedad Química y Minera de Chile
SQM
$22.5B
$18.6K ﹤0.01%
350
+250
+250% +$13.7K
NBIX icon
786
Neurocrine Biosciences
NBIX
$15.7B
$18.5K ﹤0.01%
190
RL icon
787
Ralph Lauren
RL
$21.1B
$18.5K ﹤0.01%
150
STNG icon
788
Scorpio Tankers
STNG
$3.91B
$18.5K ﹤0.01%
1,000
COR icon
789
Cencora
COR
$61.5B
$18.4K ﹤0.01%
156
CMBT
790
CMB.TECH NV
CMBT
$5.32B
$18.3K ﹤0.01%
2,000
HCA icon
791
HCA Healthcare
HCA
$90.5B
$18.3K ﹤0.01%
97
BHP icon
792
BHP
BHP
$242B
$18.3K ﹤0.01%
295
FEZ icon
793
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.52B
$18.2K ﹤0.01%
410
GAN
794
DELISTED
GAN Ltd
GAN
$18.2K ﹤0.01%
+1,000
New +$25.4K
TAK icon
795
Takeda Pharmaceutical
TAK
$57.6B
$18.2K ﹤0.01%
996
-189
-16% -$3.4K
ALLY icon
796
Ally Financial
ALLY
$12.8B
$18.1K ﹤0.01%
+400
New +$16.7K
MRAM icon
797
Everspin Technologies
MRAM
$403M
$18K ﹤0.01%
3,000
TRMB icon
798
Trimble
TRMB
$14.2B
$17.9K ﹤0.01%
230
-120
-34% -$8.67K
CVET
799
DELISTED
Covetrus, Inc. Common Stock
CVET
$17.7K ﹤0.01%
592
PEGA icon
800
Pegasystems
PEGA
$5.95B
$17.7K ﹤0.01%
310

Similar funds

RBC Europe's Q1 2021 Portfolio in Review

As of Q1 2021, RBC Europe held 1,260 positions worth $1.86B, up 6.6% from $1.75B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

RBC Europe's Q1 2021 filing shows 103 new, 238 increased, 231 reduced and 77 closed positions. Its largest new stake was iShares MSCI Global Gold Miners ETF: 152,570 shares worth $4.17M. The largest sale was Endava, an estimated $7.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RBC Europe's largest Q1 2021 buy was iShares MSCI Global Gold Miners ETF: 152,570 shares worth $4.17M.
  • RBC Europe added most to Visa in Q1 2021, an estimated $8.78M increase.
  • RBC Europe's biggest Q1 2021 reduction was Endava, cutting an estimated $7.1M.
  • RBC Europe fully exited VanEck Junior Gold Miners ETF in Q1 2021, selling an estimated $999K.
  • RBC Europe's ten largest holdings make up 53% of its $1.86B portfolio in Q1 2021.
  • RBC Europe opened 103 new positions and closed 77 in Q1 2021.
  • RBC Europe's portfolio value rose 6.6% quarter-over-quarter to $1.86B.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.